| SC 13G/A | 2016-02-12 | FMR LLC | INSMED Inc | 9,270,562 | 15.0% | EDGAR |
| SC 13G | 2016-02-12 | ORBIMED ADVISORS LLC | INSMED Inc | 1,375,200 | 2.2% | EDGAR |
| SC 13G | 2016-02-10 | VANGUARD GROUP INC | INSMED Inc | 3,205,364 | 5.2% | EDGAR |
| SC 13G/A | 2016-02-09 | PRICE T ROWE ASSOCIATES INC /MD/ | INSMED Inc | 9,276,146 | 15.0% | EDGAR |
| SC 13G/A | 2016-01-26 | BlackRock Inc. | INSMED Inc | 4,091,461 | 6.6% | EDGAR |
| SC 13G | 2015-04-10 | PRICE T ROWE ASSOCIATES INC /MD/ | INSMED Inc | 8,371,147 | 13.9% | EDGAR |
| SC 13G | 2015-02-18 | Palo Alto Investors, LLC | INSMED Inc | 4,625,648 | 9.3% | EDGAR |
| SC 13G/A | 2015-02-17 | Point72 Asset Management, L.P. | INSMED Inc | 2,840,830 | 5.7% | EDGAR |
| SC 13G/A | 2015-02-17 | Flynn James E | INSMED Inc | 2,241,631 | 4.5% | EDGAR |
| SC 13G/A | 2015-02-13 | FMR LLC | INSMED Inc | 7,449,749 | 15.0% | EDGAR |
| SC 13G/A | 2015-02-13 | Quaker BioVentures II LP | INSMED Inc | 1,975,251 | - | EDGAR |
| SC 13G/A | 2015-01-29 | BlackRock Inc. | INSMED Inc | 3,494,507 | 7.0% | EDGAR |
| SC 13G/A | 2015-01-15 | INTEGRATED CORE STRATEGIES (US) LLC | INSMED Inc | 438,616 | 0.9% | EDGAR |
| SC 13G | 2014-08-11 | Point72 Asset Management, L.P. | INSMED Inc | 2,045,392 | 5.2% | EDGAR |
| SC 13G | 2014-07-31 | Point72 Asset Management, L.P. | INSMED Inc | 2,045,392 | 5.2% | EDGAR |
| SC 13G | 2014-04-10 | Flynn James E | INSMED INC | 3,043,026 | 7.8% | EDGAR |
| SC 13G/A | 2014-02-14 | RA CAPITAL MANAGEMENT, LLC | INSMED INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2014-02-10 | Prospect Venture Partners III L P | INSMED INC | 1,069,940 | 2.7% | EDGAR |
| SC 13G | 2014-01-31 | INTEGRATED CORE STRATEGIES (US) LLC | INSMED INC | 1,419,763 | 3.6% | EDGAR |
| SC 13G | 2014-01-29 | BlackRock Inc. | INSMED INC | 2,122,048 | 5.4% | EDGAR |